Acute and Long‐Term Clinical Outcome After Endoscopic Pulmonary Vein Isolation: Results from the First Prospective, Multicenter Study. (11th September 2012)
- Record Type:
- Journal Article
- Title:
- Acute and Long‐Term Clinical Outcome After Endoscopic Pulmonary Vein Isolation: Results from the First Prospective, Multicenter Study. (11th September 2012)
- Main Title:
- Acute and Long‐Term Clinical Outcome After Endoscopic Pulmonary Vein Isolation: Results from the First Prospective, Multicenter Study
- Authors:
- METZNER, ANDREAS
WISSNER, ERIK
SCHMIDT, BORIS
CHUN, JULIAN
HINDRICKS, GERHARD
PIORKOWSKI, CHRISTOPHER
OUYANG, FEIFAN
KUCK, KARL‐HEINZ - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>Clinical Outcome After Endoscopic PVI.</bold> <italic>Introduction:</italic> The acute and long‐term outcome of pulmonary vein isolation (PVI) using an endoscopic ablation system (EAS) has only been reported in single‐center studies. The current prospective, multicenter study assessed the acute and 1‐year outcome following PVI using the EAS.</p> <p> <italic>Methods and Results:</italic> Seventy‐two patients (34 female, mean age 58 ± 10 years) with a history (5 ± 6 years) of drug‐refractory paroxysmal atrial fibrillation (AF) were included. Endoscopic PVI was performed in all patients. Follow‐up was based on regular telephone interviews, Holter ECG, and transtelephonic ECG recordings. Recurrence was defined as a symptomatic and/or documented AF episode &gt;30 seconds following a blanking period of 3 months. In 72 patients, a total of 281 pulmonary veins (PVs) were targeted and 277/281 (98.6%) PVs were isolated successfully using only the EAS. PV stenosis, thrombembolic events, pericardial effusion, pericardial tamponade, and phrenic nerve palsy occurred in 0 of 72, 0 of 72, 3 of 72 (4.2%), 4 of 72 (5.6%), and in 1 of 72 (1.4%) patients, respectively. Sixty‐seven of 72 (93.1%) patients completed a follow‐up of 365 days and 42 of 67 (62.7%) patients remained in stable sinus rhythm after a single procedure. A total of 13 of 25 (52%) patients suffering from AF recurrence<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>Clinical Outcome After Endoscopic PVI.</bold> <italic>Introduction:</italic> The acute and long‐term outcome of pulmonary vein isolation (PVI) using an endoscopic ablation system (EAS) has only been reported in single‐center studies. The current prospective, multicenter study assessed the acute and 1‐year outcome following PVI using the EAS.</p> <p> <italic>Methods and Results:</italic> Seventy‐two patients (34 female, mean age 58 ± 10 years) with a history (5 ± 6 years) of drug‐refractory paroxysmal atrial fibrillation (AF) were included. Endoscopic PVI was performed in all patients. Follow‐up was based on regular telephone interviews, Holter ECG, and transtelephonic ECG recordings. Recurrence was defined as a symptomatic and/or documented AF episode &gt;30 seconds following a blanking period of 3 months. In 72 patients, a total of 281 pulmonary veins (PVs) were targeted and 277/281 (98.6%) PVs were isolated successfully using only the EAS. PV stenosis, thrombembolic events, pericardial effusion, pericardial tamponade, and phrenic nerve palsy occurred in 0 of 72, 0 of 72, 3 of 72 (4.2%), 4 of 72 (5.6%), and in 1 of 72 (1.4%) patients, respectively. Sixty‐seven of 72 (93.1%) patients completed a follow‐up of 365 days and 42 of 67 (62.7%) patients remained in stable sinus rhythm after a single procedure. A total of 13 of 25 (52%) patients suffering from AF recurrence consented to repeat PVI using conventional radiofrequency energy 221 ± 121 days after the index procedure. LA to PV reconduction was found in 30 of 45 (67%) previously isolated PVs.</p> <p> <italic>Conclusions:</italic> A very high rate of acute electrical PVI is achieved using exclusively the EAS. The 1‐year single‐procedure success rate in patients with paroxysmal AF is comparable to conventional PVI. PV reconduction is the major determinant for AF recurrence. <italic>(J Cardiovasc Electrophysiol, Vol. 24, pp. 7‐13, January 2013)</italic></p> </abstract> … (more)
- Is Part Of:
- Journal of cardiovascular electrophysiology. Volume 24:Number 1(2013:Jan.)
- Journal:
- Journal of cardiovascular electrophysiology
- Issue:
- Volume 24:Number 1(2013:Jan.)
- Issue Display:
- Volume 24, Issue 1 (2013)
- Year:
- 2013
- Volume:
- 24
- Issue:
- 1
- Issue Sort Value:
- 2013-0024-0001-0000
- Page Start:
- 7
- Page End:
- 13
- Publication Date:
- 2012-09-11
- Subjects:
- Blood vessels -- Physiology -- Periodicals
Electrophysiology -- Periodicals
Heart -- Physiology -- Periodicals
612.1 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1111/j.1540-8167.2012.02427.x ↗
- Languages:
- English
- ISSNs:
- 1045-3873
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4954.866000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3367.xml